Cancer Metabolism: Therapeutic Targets

Targeting the mechanisms by which cancer cells acquire energy for metabolic needs is a therapeutic target. Discover the latest research on cancer metabolism and therapeutic targets.

January 12, 2021

A macromolecular drug for cancer therapy via extracellular calcification

Angewandte Chemie
Ning TangBen Wang
January 9, 2021
Open Access

Aberrant ROS Served as an Acquired Vulnerability of Cisplatin-resistant Lung Cancer

Qian XinJupeng Yuan
January 21, 2021
Open Access

Aglycemic growth enhances carbohydrate metabolism and induces sensitivity to menadione in cultured tumor-derived cells.

Cancer & Metabolism
Cameron A SchmidtP Darrell Neufer
January 1, 2021
Open Access

Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Sandipan DattaJames M Angelastro
January 3, 2021

Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment

Journal of Cancer Research and Clinical Oncology
Tongtong WeiJie Yang
December 31, 2020
Case Report
Open Access

Primary Diffuse Large B-Cell Lymphoma of the Female Urethra: A Case Report and Review of the Literature

OncoTargets and Therapy
Haiping ZengZhiqiang Chen
December 15, 2020

ANTs and cancer: Emerging pathogenesis, mechanisms, and perspectives.

Biochimica Et Biophysica Acta. Reviews on Cancer
Lin ZhaoYa Cao
January 1, 2021
Open Access

Licochalcone A inhibits hypoxia-inducible factor-1α accumulation by suppressing mitochondrial respiration in hypoxic cancer cells

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Min Kyung ParkHyun Seung Ban
January 9, 2021
Open Access

Nutritional Interventions in Cancer Cachexia: Evidence and Perspectives From Experimental Models

Frontiers in Nutrition
Wouter R P H van de WorpRamon C J Langen
January 6, 2021
Open Access

Chemoproteomics Maps Glycolytic Targetome in Cancer Cells

Haiping HaoHui Ye
December 29, 2020

Critical role of mTOR in regulating aerobic glycolysis in carcinogenesis (Review)

International Journal of Oncology
Hui FanYin Lu
January 1, 2021

Dual targeting of tumor cell energy metabolism and lysosomes as an anticancer strategy.

Biochimica Et Biophysica Acta. Molecular Cell Research
Verica PaunovicLjubica Harhaji-Trajkovic
December 17, 2020

Tumor Reliance on Cytosolic versus Mitochondrial One-Carbon Flux Depends on Folate Availability

Cell Metabolism
Won Dong LeeTomer Shlomi
January 9, 2021
Open Access

Glycolysis-induced drug resistance in tumors-A response to danger signals?

Neoplasia : an International Journal for Oncology Research
Fabrizio Marcucci, Cristiano Rumio

Sign up to follow this feed and discover related papers.

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

Cancer Disparities

Cancer disparities refers to differences in cancer outcomes (e.g., number of cancer cases, related health complications) across population groups.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

© 2021 Meta ULC. All rights reserved